BioWorld

May 21, 2010

View Archived Issues

Collins: Funding NIH Paves Way for Biotech Drug Development

Read More

NeuroTherapeutics Pharma Gets $43M Series B for Epilepsy, Pain

Read More

Other News To Note

Read More

Stock Movers

Read More

Clinic Roundup

Read More

Success Reported in Booting Up Cell Via Artificial Genome

For 15 years, scientists at the J. Craig Venter Institute have been pursuing the goal of controlling a real cell with a synthetic genome. And in the May 21, 2010, edition of Science, they reported success. (BioWorld Today) Read More

Santhera's Idebenone Falls Short in Second Pivotal Trial

Read More